Chris Jenkins
Founder, CEO, Principal Partner
Marala McCallister
Chief Operations Officer
Melissa Fink
Director of IRB Operations
David Emery
Director of Institutional Biosafety Committee (IBC) Operations
Melissa Fitzgerald
IRB Analyst
Shaun Tamprateep
IT and Operational Systems Architect
Rachel DePriest
Administrative and Accounts Specialist

Mission Statement

The mission of Castle IRB is to protect the rights and welfare of human participants in gene and cell therapy clinical trials while providing efficient, compliant IRB review of research. Using our portfolio of expertise, we strive to be the leading IRB partner in advancing safe, ethical and compliant gene and cell therapy clinical trials to accelerate the next evolution in advanced therapies.